Established in 2017, Vitaccess delivers real data from real people through real trust to trigger digital, patient and human progress, using the powerful combination of its novel Vitaccess Real™ digital platform and expert consultative insight.

Running global digital real-world evidence studies, Vitaccess can help biopharmaceutical companies to measure the impact of diseases and treatments on people's daily lives in real time. The findings of these studies help researchers improve healthcare and make a positive impact on the lives of patients affected by these conditions.

Vitaccess has grown at pace and gained considerable recognition for the advances it is making, recently nominated as a Tech Nation Top 33 Upscale 6.0 participant as well as a recipient of Innovate UK funding. It is the winner of several science and business awards, including a Queen's Awards for Enterprise in 2021, the 2020 Reuters Pharma Awards and the Barclays Scale-up Entrepreneur of the Year 2020.

A growing 50-strong team, the company is passionate about inclusivity and open ways of working. All seek new ways to harness the power of technology for the good of health, and to help generate insights that can change the real-world experiences of patients.